文献速递细菌感染、耐药与抗菌药物医院感染防控

血液肿瘤患者直肠定植多重耐药革兰阴性菌与后续菌血症

Rectal colonization by multidrug-resistant Gram-negative bacteria and subsequent bacteraemia in haematological patients.
PubMed 文献 · Clin Microbiol Infect · 2025-06-05

该回顾性分析纳入699例血液肿瘤患者,每周直肠拭子筛查多重耐药革兰阴性菌(MDR-GNB)定植,探究定植与后续血流感染(BSI)的关系。结果显示192例(27.5%)患者定植,定植者BSI发生率38.5%高于非定植者12.0%;MDR-GNB所致BSI多发生于定植患者。

要点

  • 699例血液肿瘤患者中192例(27.5%)直肠拭子检出MDR-GNB定植。
  • 定植患者BSI发生率38.5%(74/192)高于非定植者12.0%(61/507)。
  • MDR-GNB所致BSI中87.7%(50/57)发生于定植患者。

核心结论

  • 血液肿瘤患者每周直肠拭子MDR-GNB监测可早期识别定植,且定植常先于MDR-GNB血流感染发生。
  • 需进一步校正分析研究以确立其独立预测价值。

研究设计与样本

  • 回顾性分析,2020年1月至2022年9月血液科病房住院患者每周直肠拭子筛查MDR-GNB定植。
  • 共纳入699例患者,采集3024份直肠拭子。
  • MDR-GNB定义依据2022年欧洲临床微生物与感染性疾病学会标准,包括3GCephRE、CRE、DTR铜绿假单胞菌和碳青霉烯耐药鲍曼不动杆菌。

主要发现

  • 3024份直肠拭子中503份(16.6%)MDR-GNB阳性,对应192/699例患者(27.5%)。
  • 检出菌种以大肠埃希菌(248/503,49.3%)、肺炎克雷伯菌复合群(125/503,24.9%)和铜绿假单胞菌(36/503,7.2%)为主。
  • CRE定植59/503(11.7%);入院时定植27/192例(14.1%),主要为3GCephRE(27/29,93.1%)。
  • BSI发生于定植者74/192例(38.5%)和非定植者61/507例(12.0%)。
  • MDR-GNB引起57/166次BSI,其中50/57(87.7%)发生于定植患者。

关键数值与推荐

  • 直肠拭子与血培养一致率:定植患者90次BSI中43次(47.8%)。
  • DTR铜绿假单胞菌:PPV 36.4%,NPV 99.9%。
  • CRE:PPV 25.0%,NPV 99.9%。
  • 3GCephRE:PPV 14.6%,NPV 99.0%。

临床怎么用

  • 对血液肿瘤患者可每周直肠拭子筛查MDR-GNB定植,以早期识别定植并预警后续MDR-GNB BSI风险。
  • 定植筛查阴性预测值高(DTR铜绿假单胞菌和CRE均为99.9%,3GCephRE为99.0%),但阳性预测值较低。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study assessed the prevalence of multidrug-resistant Gram-negative bacilli (MDR-GNB) colonization in rectal swabs from haematological patients with malignancies undergoing routine surveillance and explored the relationship between MDR-GNB colonization and subsequent development of bloodstream infections (BSIs). METHODS: Between January 2020 and September 2022, all patients admitted to our haematology ward underwent weekly MDR-GNB colonization screening via rectal swabs. A retrospective analysis was performed. MDR-GNB were defined per 2022 European Society of Clinical Microbiology and Infectious Diseases criteria: (a) third-generation cephalosporin-resistant Enterobacterales (3GCephRE), (b) carbapenem-resistant Enterobacterales (CRE), (c) Pseudomonas aeruginosa with difficult-to-treat resistance (DTR), and (d) carbapenem-resistant Acinetobacter baumannii. RESULTS: Among 3024 rectal swabs from 699 patients, 503 of 3024 (16.6%) tested positive for MDR-GNB in 192 of 699 patients (27.5%). The most prevalent organisms were Escherichia coli (248/503; 49.3%), Klebsiella pneumoniae complex (125/503; 24.9%), and P. aeruginosa (36/503; 7.2%). A total of 59 of 503 (11.7%) colonizations of CRE were identified. Overall, 27 of 192 (14.1%) patients were colonized at admission, primarily by 3GCephRE (27/29; 93.1%). Colonization with CRE and DTR P. aeruginosa was more frequently documented after several days of hospitalization. BSI occurred in 74 of 192 (38.5%) colonized and 61 of 507 (12.0%) non-colonized patients. MDR-GNB caused 57 of 166 BSIs episodes, 50 of 57 (87.7%) of which were in colonized patients. The unadjusted concordance rate between rectal swab isolates and blood cultures was observed in 43 of 90 BSIs (47.8%) occurring in colonized patients, with a positive predictive value (PPV) of 36.4% and a negative predictive value (NPV) of 99.9% for DTR P. aeruginosa; a PPV of 25.0% and an NPV of 99.9% for CRE; and a PPV of 14.6% and an NPV of 99.0% for 3GCephRE. DISCUSSION: Routine weekly surveillance for MDR-GNB in haematological patients enables early identification of colonization, often preceding MDR-GNB BSIs. Further studies using adjusted analyses are needed to establish its independent predictive value.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Gallardo-Pizarro A, Lopera C, Peyrony O, et al. Rectal colonization by multidrug-resistant Gram-negative bacteria and subsequent bacteraemia in haematological patients. Clin Microbiol Infect. 2025. PMID: 40482885. doi:10.1016/j.cmi.2025.05.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。